Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arnica montana and Bellis perennis for Seroma Prevention
NCT03512639Completed
- Sponsor
- Shaare Zedek Medical Center
- Start
- Jan 2016
- Primary completion
- Aug 2017
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of arnica montana and bellis perennis in Seroma (2 arms), sponsored by Shaare Zedek Medical Center. Primary endpoint: Reduction of post operative seroma at 18 months. Started Jan 2016; status: completed.
02
Drugs
arnica montanabellis perennis
03
Conditions
Seroma
Beyond the preview
Go deeper on NCT03512639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03512639.